“Drug Resistance by using the inhA promoter in clinical isolate for Mycobacterium Tuberculosis cases”, Int J of Biomed & Adv Res, vol. 10, no. 12, p. e5205, Dec. 2019, doi: 10.7439/ijbar.v10i12.5205.